| Literature DB >> 34971753 |
Sergio Ortiz-Espinosa1, Xabier Morales2, Yaiza Senent1, Diego Alignani3, Beatriz Tavira4, Irati Macaya5, Borja Ruiz5, Haritz Moreno5, Ana Remírez6, Cristina Sainz6, Alejandro Rodriguez-Pena2, Alvaro Oyarbide2, Mikel Ariz2, Maria P Andueza7, Karmele Valencia8, Alvaro Teijeira9, Kai Hoehlig10, Axel Vater10, Barbara Rolfe11, Trent M Woodruff11, Jose Maria Lopez-Picazo12, Silvestre Vicent13, Grazyna Kochan14, David Escors14, Ignacio Gil-Bazo15, Jose Luis Perez-Gracia16, Luis M Montuenga13, John D Lambris17, Carlos Ortiz de Solorzano18, Fernando Lecanda6, Daniel Ajona19, Ruben Pio8.
Abstract
Myeloid-derived suppressor cells (MDSCs) play a major role in cancer progression. In this study, we investigated the mechanisms by which complement C5a increases the capacity of polymorphonuclear MDSCs (PMN-MDSCs) to promote tumor growth and metastatic spread. Stimulation of PMN-MDSCs with C5a favored the invasion of cancer cells via a process dependent on the formation of neutrophil extracellular traps (NETs). NETosis was dependent on the production of high mobility group box 1 (HMGB1) by cancer cells. Moreover, C5a induced the surface expression of the HMGB1 receptors TLR4 and RAGE in PMN-MDSCs. In a mouse lung metastasis model, inhibition of C5a, C5a receptor-1 (C5aR1) or NETosis reduced the number of circulating-tumor cells (CTCs) and the metastatic burden. In support of the translational relevance of these findings, C5a was able to stimulate migration and NETosis in PMN-MDSCs obtained from lung cancer patients. Furthermore, myeloperoxidase (MPO)-DNA complexes, as markers of NETosis, were elevated in lung cancer patients and significantly correlated with C5a levels. In conclusion, C5a induces the formation of NETs from PMN-MDSCs in the presence of cancer cells, which may facilitate cancer cell dissemination and metastasis.Entities:
Keywords: C5a/C5aR1; HMGB1; Lung metastasis; Myeloid-derived suppressor cells; NETosis
Mesh:
Substances:
Year: 2021 PMID: 34971753 DOI: 10.1016/j.canlet.2021.12.027
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679